Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
03/1998
03/18/1998EP0525119B1 Antibody conjugates for treatment of neoplastic disease
03/18/1998EP0506845B1 Uncharged morpholino-based polymers having achiral intersubunit linkages
03/18/1998EP0460232B1 Tumor cell growth inhibitor
03/18/1998CN1176658A Vaccine and antitoxin for treatment and prevention of C. difficile disease
03/18/1998CN1176599A Pharmaceutical composition for piperidinoalkanol compounds
03/18/1998CN1176139A Fowl Marek's disease vaccine sgnergist and its preparation
03/18/1998CN1176138A The use of (meth) acrylic acid/maleic acid copolymers for improving mucosal permeability
03/17/1998USRE35748 Proteins of collagen and fibrinogen for drugs
03/17/1998US5728868 Prodrugs of protein tyrosine kinase inhibitors
03/17/1998US5728752 Lactone polymers
03/17/1998US5728738 Mixing alkali with sodium mercaptoethylsulfonate
03/17/1998US5728735 Pharmaceutical composition containing R-α-lipoic acid or S-α-lipoic acid as active ingredient
03/17/1998US5728690 Hydrocortisone, sodium dioctyl sulfosuccinate, polyoxyethylene glycol, buffers and preservatives
03/17/1998US5728680 Methods for normalizing numbers of lymphocytes
03/17/1998US5728590 Small organometallic probes
03/17/1998US5728560 Treating hiv-infected patients using adenosine deaminase
03/17/1998US5728553 High purity albumin and method of producing
03/17/1998US5728537 Antigen immunogens for cancer detection in epithelial fluids
03/17/1998US5728521 Targeted cleavage of RNA using eukaryotic ribonuclease P and external guide sequence
03/17/1998US5728518 Soluble complex of a poly- or oligonucleotide and a carrier
03/17/1998US5728399 Use of a bacterial component to enhance targeted delivery of polynucleotides to cells
03/17/1998US5728392 Cosmetic and/or dermatological composition for the treatment of aging, containing ceramides, and the use thereof
03/17/1998US5728390 Cosmetic composition of an alpha or beta-hydroxy acid and a polyvinylpyrrolidone complexing agent
03/17/1998US5728383 Treatment of tumors of the central nervous system with immunotoxins
03/17/1998US5728375 Method for treating amyloidosis
03/17/1998CA2185600A1 Water-soluble concentrates containing cyclosporins
03/17/1998CA1339737C Fibrin-specific and fibrinogen-specific monoclonal antibodies and their derivation from immunized germ free mice
03/12/1998WO1998009989A1 The use of muramylpeptides in the treatment of myelosuppressed or otherwise immunocompromised states
03/12/1998WO1998009654A1 Pharmaceutical composition containing lornoxicam and a disodic salt of edta
03/12/1998WO1998009651A1 ANTI-INTEGRIN α3 ANTIBODY COMPLEXES
03/12/1998WO1998009645A1 Peptide-containing drug compositions for oral administration
03/12/1998WO1998009613A1 Process to manufacture implants containing bioactive peptides
03/12/1998WO1998009533A1 Cocoa components, edible products having enhanced polyphenol content, methods of making same and medical uses
03/12/1998WO1998002146A3 Chemo-mechanical expansion delivery system
03/12/1998WO1998001161A3 Gene therapy delivery system for targeting to endothelia
03/12/1998WO1997049431A3 Use of oligosaccharides for neutralising e. coli toxins
03/12/1998WO1997046262A3 Membrane incorporation of texaphyrins
03/12/1998WO1997046259A3 Chimeric toxin for targeted therapy
03/12/1998WO1997041895A3 TREATMENT OF ASTHMA WITH TNFR-Ig
03/12/1998WO1997040854A3 Polypeptide conjugates for transporting substances across cell membranes
03/12/1998DE19636889A1 Antineoplastisch wirkende Transferrin- und Albuminkonjugate zytostatischer Verbindungen aus der Gruppe der Anthrazykline, Alkylantien, Antimetabolite und Cisplatin-Analoga und diese enthaltende Arzneimittel Antineoplastic acting transferrin and albumin conjugates cytostatic compounds from the group of anthracyclines, alkylating agents, antimetabolites and cisplatin analogues and pharmaceutical compositions containing them
03/12/1998CA2795629A1 Cocoa components, edible products having enhanced polyphenol content, methods of making same and medical uses
03/12/1998CA2265890A1 The use of muramylpeptides in the treatment of myelosuppressed or otherwise immunocompromised states
03/12/1998CA2236595A1 Process to manufacture implants containing bioactive peptides
03/11/1998EP0827750A2 Obesity protein formulations
03/11/1998EP0827749A2 Peritoneal dialysis solution
03/11/1998EP0827748A2 Peritoneal dialysis solution
03/11/1998EP0827741A2 Composition for transdermal delivery system containing nonsteroidal anti-inflammatory drug as an active ingredient
03/11/1998EP0827514A1 Heavy metal salts of succinic acid hemiesters with hyaluronic acid, or hyaluronic acid esters, a process for their preparation, and relative pharmaceutical compositions
03/11/1998EP0827513A1 Methods of treatment and diagnostic visualisation, particularly in cancer
03/11/1998EP0827402A2 Compositions containing fatty acids for improving digestion and absorption in the small intestine
03/11/1998EP0827398A1 Pharmaceutical dosage form for colonic delivery
03/11/1998EP0827397A2 Three-phase pharmaceutical form with constant and controlled release of amorphous active ingredient for single daily application
03/11/1998EP0827396A1 Production scale method of forming microparticles
03/11/1998EP0827394A1 Sterilisable paste product for topical application
03/11/1998EP0677126B1 Antiviral topical pharmaceutical compositions
03/11/1998EP0660717B1 Aminosteroids for ophthalmic use
03/11/1998EP0659081B1 Dexpanthenol-containing plaster for the transdermal application of steroid hormones
03/11/1998EP0556178B1 Use of protease nexin-i to mediate wound healing
03/11/1998EP0552188B1 Treatment of tumorigenic pathophysiological conditions with fgf-cytotoxic conjugates
03/11/1998CN1175904A Use of inorganic aerogels in pharmacy
03/11/1998CN1175902A Method and compositions for lipidization of hydrophilic molecules
03/11/1998CN1175886A Use of aerogels in agriculture
03/11/1998CN1175465A Process for manufacture of pharmaceutical composition containing polyethylene glycol protein conjugates
03/10/1998US5726329 Modified phosphorous intermediates for providing functional groups on the 5' end of oligonucleotides
03/10/1998US5726209 Liquid fluorocarbon emulsion as a vascular nitric oxide reservoir
03/10/1998US5726201 Bis-(2-ethylhexyl)-sodium-sulfosuccinate surfactant; storage stability; uniform dissolution
03/10/1998US5726190 Agonist-antagonist combination to reduce the use of nicotine and other drugs
03/10/1998US5726181 Formulations and compositions of poorly water soluble camptothecin derivatives
03/10/1998US5726180 Caffeine, dextromethorphan, phenylpropanolamine, ibuprofen
03/10/1998US5726169 Chlorophyll and bacteriochlorophyll derivatives, their preparation and pharmaceutical compositions comprising them
03/10/1998US5726166 Inositol monophosphate or a phosphatidyl inositol
03/10/1998US5726164 Nanosuspensions for intravenous administration
03/10/1998US5726161 Bound starch particles with voids containing functional substances, i.e., insecticides, herbicides, vitamins, bacteriostats and drugs for sustained release; drug delivery
03/10/1998US5726160 Treatment of diseases such as cystic fibrosis, emphysema, bronchitis and sinusitis
03/10/1998US5725886 Microcrystalline cellulose spheronization composition
03/10/1998US5725884 Cellulose excipients, slurrying with silicon dioxide, agglomeration and drying
03/10/1998US5725883 Microcrystalline cellulose
03/10/1998US5725880 Pharmaceutical preparation controlled to release medicinal active ingredient at targeted site in intestinal tract
03/10/1998US5725874 Menthoxypropanediol
03/10/1998US5725873 Method of improving the growth or the efficiency of feed conversion of an animal and compositions for use therein
03/10/1998US5725871 Drug delivery compositions comprising lysophosphoglycerolipid
03/10/1998US5725865 Monomenthyl succinate or salts
03/10/1998US5725864 Contacting susceptible lymphoid cells with antiviral amount of iron-binding protein or derivative thereof
03/10/1998US5725857 Immunotoxin with in vivo T cell suppressant activity and methods of use
03/10/1998US5725856 Anticarcinogenic agents and antitumor agents
03/10/1998US5725852 Cytidine diphosphate choline absorption promoter
03/10/1998US5725841 Aerosol formulation containing an ester-, amide-, or mercaptoester-derived dispersing aid
03/10/1998US5725839 Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules for ERI or MRI
03/10/1998US5725804 Non-crosslinked protein particles for therapeutic and diagnostic use
03/10/1998US5725491 Spraying thermoplastic polymer in solvent
03/10/1998CA1339709C Monoclonal antibodies to human pancreatic cancer
03/10/1998CA1339707C Formulations for recombinant beta-interferon
03/05/1998WO1998008966A1 Loxoprofen-containing preparation for external use
03/05/1998WO1998008957A1 Compositions and methods for specifically targeting tumors
03/05/1998WO1998008897A1 Polycarboxylic based cross-linked copolymers
03/05/1998WO1998008884A1 Hydrophilic and hydrophobic polyether polyurethanes and uses therefor
03/05/1998WO1998008871A1 Glp-1 derivatives
03/05/1998WO1998008859A1 Bioconjugates and delivery of bioactive agents
03/05/1998WO1998008550A1 Fragmented polymeric hydrogels for adhesion prevention and their preparation
1 ... 1472 1473 1474 1475 1476 1477 1478 1479 1480 1481 1482 1483 1484 1485 1486 1487 1488 1489 1490 1491 1492 ... 1712